IMAX Stock Eyes Second Weekly Gain: ‘The Odyssey’ Moment Has Wall Street Reassessing Its Growth Outlook
Goldman Sachs raised its price target to $42 while keeping a ‘Neutral’ rating and highlighting execution risks.
Archived explainer. For the current picture see today's IMAX page.
IMAX CORP (IMAX) is up +11.86% in the latest session. Our newswire has captured 13 stories on IMAX across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
IMAX stock surged 11.86 percent to $43.96 on July 23, 2026, driven by strong second-quarter earnings and a record-breaking box office performance. The company reported adjusted earnings per share of $0.43, surpassing the $0.28 estimate, and revenue of $102.8 million, exceeding the $93.746 million estimate. The success of Christopher Nolan’s film "The Odyssey" significantly boosted IMAX’s global box office results and fueled investor optimism.
IMAX reported Q2 2026 results that exceeded both revenue and earnings expectations, with the record-breaking debut of "The Odyssey" playing a central role. The film drove a surge in ticket sales and profitability, with the company reporting double-digit revenue growth and rising operating margins. The company also reaffirmed its $1.4 billion global box office target for 2026, citing continued system demand and strong execution. Goldman Sachs raised its price target to $42 while maintaining a Neutral rating, noting the positive momentum but highlighting execution risks. The earnings call emphasized record EPS, system signings, and the company’s strategic expansion.
IMAX is currently trading at a price-to-earnings ratio of 59.8, with a market capitalization of $2.1 billion. The stock has a 52-week range of $24.20 to $45.52 and is up 12.6 percent year-to-date in revenue. Recent unusual options activity included two notable prints, with put premiums totaling $1.3 million and the largest single print at $994,000. The stock’s beta of 0.37 suggests it is less volatile than the broader market.
Investors should focus on the company’s upcoming earnings report and how it aligns with the $1.4 billion box office target. Continued performance from "The Odyssey" and the company’s global expansion efforts will be key indicators of future momentum.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
Goldman Sachs raised its price target to $42 while keeping a ‘Neutral’ rating and highlighting execution risks.
IMAX Q2 2026 earnings call recap: The Odyssey-driven box office surge, record EPS, system signings, and $1.4B outlook—get key investor takeaways now.
IMAX Corporation (IMAX) Q2 2026 Earnings Call July 23, 2026 8:30 AM EDTCompany ParticipantsJennifer Horsley - Senior VP & Head of Investor...
2026-07-23. The following slide deck was published by IMAX Corporation in conjunction with their 2026 Q2 earnings call.
Nolan's "The Odyssey" is racking up box office dollars for IMAX and fueling investor confidence that the company will reach a record ticket sales in 2026.
IMAX beat second-quarter earnings and revenue expectations as the record-breaking debut of The Odyssey boosted box office performance, profitability and global network expansion.
IMAX exceeded expectations with double-digit revenue growth and surged operating margins in Q2 2026, fueled by record-breaking box office results and a standout performance from 'The Odyssey.' The company posted its highest Q2 systems installations in a decade, made significant share buybacks, and expanded internationally outside China by 9%, setting the stage for a robust second half with major film releases.
More on IMAX: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier IMAX move explainers: 2026-07-24 · 2026-07-23